Millipore Corp Acquired By Merck KGaA For US$7.2bn

US-based company Millipore Corp has been acquired by German drugmaker Merck KGaA in a deal valued at US$7.2bn, with Merck KGaA set to acquire all outstanding shares of common stock of Millipore, for US$107 per share in cash. According to Reuters, the deal snatches Millipore away from rival bidder Thermo Fischer Scientific, which had offered US$6bn. It is believed that General Electric was also among the bidders for the life sciences company.

To read the full article, please sign in or take a free trial.